In addition, SAM domain proteins can be implicated in human pathogenic mechanisms, e.g. SAMD9 and SAMD9L mutations are linked to bone marrow failure that can progress to myeloid malignancies (28, 29). Here, SAMD9L is linked to myeloid neoplasm.